跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
OXLUMO 94,5 mg/0,5 ml SOLUCION INYECTABLE - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
OXLUMO 94,5 mg/0,5 ml SOLUCION INYECTABLE
Approved
STANDARD
OXLUMO 94,5 mg/0,5 ml SOLUCION INYECTABLE
Alnylam Netherlands B.V.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Dec 30, 2020
Approval ID
d10fecb419afb56b
Company
Alnylam Netherlands B.V.
Type
Standard
Approval Details
Approval Id
d10fecb419afb56b
Drug Cima Aemps Name
OXLUMO 94,5 mg/0,5 ml SOLUCION INYECTABLE
Register Number
1201496001
Holder Company Name
Alnylam Netherlands B.V.
Marketing Company Name
Alnylam Pharmaceuticals Spain, S. L.
Holder Company Detail Path
/organization/alnylam-netherlands-bv
Authorization Date
2020-12-30
Dosage Form
SOLUCIÓN INYECTABLE
Dose
189 mg/ml
Route Of Administration
VÍA SUBCUTÁNEA
Prescription Type
Uso Hospitalario
Commercialized
Yes
Company Name
Alnylam Netherlands B.V.
Company Detail Path
/organization/alnylam-netherlands-bv
Company Information
Pharmaceutical Company Name
Alnylam Netherlands BV
Country Name
Netherlands
Website
http://www.alnylam.com/alnylam-netherlands
Active Ingredients
LUMASIRAN SODIO
100 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Dec 30, 2020
Approval ID
d10fecb419afb56b
Type
Standard
Back to CIMA-AEMPS Approvals